VIEWS: 2 PAGES: 2 CATEGORY: Press Releases POSTED ON: 4/27/2013
BALA CYNWYD, Pa.--(BUSINESS WIRE)--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of PROLOR Biotech, Inc. (“PROLOR” or the “Company”) (NYSE: PBTH) relating to the proposed acquisition by OPKO Health, Inc. (“OPKO”). Under the terms of the transaction, PROLOR shareholders will receive only 0.9951 shares of OPKO stock for each share of PROLOR stock they own. The transaction values PROLOR stock at approximately $7.025 per sha a style='fon
"Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc"